The Cooper Companies, Inc. $COO Shares Sold by Northern Trust Corp

Key Points

• Northern Trust Corp has reduced its stake in The Cooper Companies, Inc. by 1.0%, owning 1,999,116 shares worth approximately $168.6 million as of the latest SEC filing.
• Analysts have mixed views on Cooper Companies, with one rating it as a Strong Buy, while others set price targets ranging from $90.00 to $105.00, indicating a generally favorable outlook.
• The stock opened at $73.04 and has shown a year-over-year revenue growth of 6.3%, with earnings per share for the latest quarter reported at $0.96, exceeding analysts' expectations.

Northern Trust Corp reduced its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 1.0% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,999,116 shares of the medical device company's stock after selling 19,782 shares during the quarter. Northern Trust Corp owned approximately 1.00% of Cooper Companies worth $168,625,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of COO. Raymond James Financial Inc. raised its holdings in Cooper Companies by 2.1% during the first quarter. Raymond James Financial Inc. now owns 719,725 shares of the medical device company's stock valued at $60,709,000 after acquiring an additional 14,561 shares during the period. American Century Companies Inc. raised its holdings in Cooper Companies by 0.9% during the first quarter. American Century Companies Inc. now owns 45,616 shares of the medical device company's stock valued at $3,848,000 after acquiring an additional 406 shares during the period. EverSource Wealth Advisors LLC raised its holdings in Cooper Companies by 3.5% during the first quarter. EverSource Wealth Advisors LLC now owns 6,517 shares of the medical device company's stock valued at $550,000 after acquiring an additional 220 shares during the period. Dimensional Fund Advisors LP raised its holdings in Cooper Companies by 4.1% during the first quarter. Dimensional Fund Advisors LP now owns 1,621,839 shares of the medical device company's stock valued at $136,793,000 after acquiring an additional 63,681 shares during the period. Finally, Horizon Investments LLC raised its holdings in Cooper Companies by 5.0% during the first quarter. Horizon Investments LLC now owns 2,859 shares of the medical device company's stock valued at $241,000 after acquiring an additional 136 shares during the period. 24.39% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have commented on COO. JPMorgan Chase & Co. reissued a "neutral" rating and set a $76.00 price target (down from $110.00) on shares of Cooper Companies in a report on Friday, May 30th. BNP Paribas raised Cooper Companies from a "hold" rating to a "strong-buy" rating in a report on Tuesday, July 22nd. Wall Street Zen cut Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. Mizuho decreased their price target on Cooper Companies from $105.00 to $90.00 and set an "outperform" rating on the stock in a report on Wednesday, July 16th. Finally, BNP Paribas Exane raised Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price target on the stock in a report on Tuesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $96.73.

Cooper Companies Stock Up 3.0%

Cooper Companies stock traded up $2.18 during mid-day trading on Friday, reaching $75.22. 1,992,159 shares of the company were exchanged, compared to its average volume of 1,597,715. The business has a fifty day moving average of $72.18 and a 200 day moving average of $78.08. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.23 and a current ratio of 2.10. The firm has a market cap of $15.04 billion, a P/E ratio of 36.51, a PEG ratio of 1.83 and a beta of 1.00. The Cooper Companies, Inc. has a 12-month low of $65.00 and a 12-month high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, topping analysts' consensus estimates of $0.93 by $0.03. The company had revenue of $1 billion during the quarter, compared to analyst estimates of $995.12 million. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%.Cooper Companies's revenue was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.85 earnings per share. Cooper Companies has set its FY 2025 guidance at 4.050-4.110 EPS. Research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.